Ziniu Medical Entrepreneur Camp Launches Successfully, Unveiling Investment Strategy in Healthcare Sector

VCBeat (WeChat ID: vcbeat) has learned that the opening ceremony of the “Purple Cow Medical Startup Camp” was held at the New World Hotel in Beijing on July 20, 2019. Dozens of representatives from medical investment funds, leading industry enterprises, as well as industry experts and scholars attended the event, engaging in in-depth discussions on “the reconstruction and upgrading of healthcare scenarios driven by new technologies.” The opening ceremony was hosted by PURPLE COW STARTUPS, with co-organization support from Commerce & Finance Law Offices and Shangyi Tax and Accounting Services.

Zhang Quanling, Founding Partner of PURPLE COW STARTUPS, shared the firm’s investment logic in the healthcare sector during her address at the opening ceremony. She stated that changes in the technology and user axes are key considerations in PURPLE COW STARTUPS’ healthcare investments.

Based on this, Zhang Quanling categorizes PURPLE COW STARTUPS’ investment projects into four interconnected quadrants: (1) existing technologies meeting existing needs; (2) future technologies meeting existing needs; (3) existing technologies meeting future needs; and (4) future technologies meeting future needs.

Regarding forecasts of the future landscape, Zhang Quanling stated that macroeconomic trends may not be the most critical factor. In the era of data interconnectivity, it is essential to drive the fragmentation and reconfiguration of value chains, thereby forming entirely new value networks. It is this transition from value chains to value networks that will profoundly impact the business community. Entrepreneurs must reflect on the following: Who can I connect with? Who can connect with me? Where are my data collaborators? Rather than being squeezed out as participants in traditional value chains, strive to become beneficiaries within emerging value networks.

Zhang Quanling, Founding Partner of PURPLE COW STARTUPS

Yu Bo, Head of Healthcare at PURPLE COW STARTUPS, stated that based on the fundamental formula “Healthcare Services = Expert Expertise + Tool Implementation,” the underlying investment logic of PURPLE COW STARTUPS in the healthcare sector is to “drive improvements in healthcare service productivity.” Within this framework, cultivating more experts and scholars and creating newer, better tools represent two basic pathways, with the latter being more suitable for investment institutions.

Regarding specific investment dimensions, Yu Bo stated that PURPLE COW STARTUPS primarily expands horizontally across three major disease categories: malignant tumors, cardiovascular and cerebrovascular/geriatric diseases, and severe infectious diseases. Vertically, it extends its focus within the diagnosis and treatment workflow by concentrating on the two key stages of diagnosis and therapy. On this basis, technological maturity and cross-disciplinary technological integration are the key areas of focus for PURPLE COW STARTUPS.

Regarding future trends, Yu Bo proposed four keywords: “technological innovation, grassroots empowerment, service outsourcing, and import substitution.”

Yu Bo, Head of Healthcare at PURPLE COW STARTUPS

Across the medical sectors and projects focused on by PURPLE COW STARTUPS, technological innovation and tech-enabled empowerment have been consistent themes. During the thematic sharing session, guests from United Imaging Healthcare, General Electric, Meinian Onehealth, Anhan Medical, and Kangda Medical respectively shared their practices and insights on this topic.

Cai Tao, Senior Vice President and Chief Investment Officer of United Imaging Healthcare, analyzed the current state of the high-end medical equipment industry from a global perspective. He pointed out that due to high R&D technical barriers, China’s market for high-end medical equipment was heavily reliant on imported products in the past. The significant lag in development compared to developed countries represents a major pain point for the industry, reflecting the underlying issue of domestic shortages in medical resources.

To help change this status quo, United Imaging has built a multi-dimensional innovation matrix encompassing technology, services, and marketing. It has achieved independent research and development of all key components and core technologies, established patent barriers, and conducted extensive cutting-edge research innovations, industry-academia-research collaborative innovations, and customized innovations, aiming to create a highland for talent in China’s high-end medical equipment industry.

Cai Tao, Senior Vice President and Chief Investment Officer of United Imaging Healthcare

Wang Huayi, Head of the Digital Platform in the R&D Department of GE Healthcare China, introduced GE Healthcare’s strategic layout in China and focused on sharing its digital strategy and solutions in the country. These included the open ecosystem architecture of the Edison artificial intelligence platform and discussions on future collaboration opportunities with AI startups.

Wang Huayi, Head of Digitalization, R&D Department, GE Healthcare China

Jiang Weina, Vice Dean of the Zhongguancun Meinian Health Industry Research Institute, stated that the health checkup industry is now entering a phase of rapid growth, driven by the trend of population aging and gradually increasing penetration rates in lower-tier cities. Against this backdrop, Meinian aims to expand its service scope, build a comprehensive closed-loop ecosystem centered on its health checkup business, and focus on technological innovation in preventive medicine.

Jiang Weina, Deputy Director of the Zhongguancun Meinian Health Industry Research Institute

Xiao Guohua, founder of Anhan Medical, shared his insights from years of entrepreneurship and offered advice to fellow entrepreneurs: in pursuing medical startup ventures, greater emphasis should be placed on medical value alongside economic value. The significance of profit margins for startups lies not in how much money is earned initially, but in whether a favorable gross margin can be achieved over the course of dynamic development in the future.

Xiao Guohua, Founder of Anhan Medical

Feng Dali, Vice President and Board Secretary of Kangda Medical, provided an in-depth interpretation and case studies on Kangda’s path to survival and development. He pointed out that the lack of top-tier R&D teams, systematic management experience, substantial financial support, and abundant government resources are the main bottlenecks currently faced by small and medium-sized enterprises (SMEs) in their development. In response, Kangda has summarized three major strategies from its development experience: offering high-quality products at low prices, implementing platform-based operations, and expanding value-added services.

Feng Dali, Vice President and Board Secretary of Kangda Medical

The appointment ceremony for the mentors of the first cohort of the PURPLE COW STARTUPS Medical Entrepreneurship Camp was successfully held on-site. Eighteen industry veterans and distinguished investors were appointed as special mentors for the “PURPLE COW Entrepreneurship Camp,” with Li Yong, Partner at PURPLE COW STARTUPS, presenting them with their “Mentor Certificates.” Led by PURPLE COW STARTUPS, the mentors will join forces to provide comprehensive guidance to camp participants, supporting and accompanying enterprises throughout their growth journey. They also shared their profound insights into the industry at the event.

Wang Haijiao, Executive Partner at GTJA Capital, stated that as China’s healthcare system transitions from the eras of “funding hospitals through fiscal revenue” and “sustaining hospitals with drug profits” to a new phase of “promoting healthcare through insurance coverage,” systematic changes have already occurred at the macro level. In specific sectors, areas such as generic drugs and medical devices will enter a stage dominated by centralized procurement, where success will hinge on scale. From an investment perspective, China’s healthcare investment has undergone a fundamental shift from prioritizing marketing to emphasizing technology. Looking ahead, while financing and investment activities in the healthcare sector are not expected to be significantly impacted, both entrepreneurs and investors will face intensified competition from public markets. “Seeking efficiency through scale and innovation” will become an inevitable path for project development.

Wang Haijiao, Executive Partner of GTJA Capital

Sean Xia, a senior investor in the healthcare private equity sector, outlined five key investment perspectives in his speech: First, the industry has entered a phase of stable growth, and investors should focus more on structural opportunities. Second, as social demands emerge and evolve, new market opportunities will continue to arise in niche segments. Third, while seizing opportunities in niche business models, investors must also learn to create opportunities. Fourth, investors should pay attention to multi-type arbitrage and post-investment value-addition opportunities. Fifth, focus on the stratification and differentiation opportunities within companies and industries. “Even though the current market faces pressure, there are still opportunities if execution is on point. Successful entrepreneurship requires the most rugged physique, the most civilized mind, and an indomitable spirit.”

Sean Daxia, Senior Investor in Healthcare PE & Media Professional

Xu Jingbo, Senior Investment Director at Fosun Pharma, believes that the in vitro diagnostics (IVD) market is the largest segment within the medical diagnostics industry. However, growth rates for clinical diagnostics and point-of-care testing (POCT) are slowing, and the current landscape is characterized by fragmented manufacturers and relatively low technological standards. Overall, investment in the IVD sector remains a hotspot, with molecular diagnostics, import substitution, laboratory automation, and microfluidics emerging as key areas of investor interest. “In the future, factors such as the China-US trade war, the adoption of the ‘4+7’ centralized procurement policy, reductions in testing fees, and the launch of the STAR Market will create a new environment influencing industry development. The sector will face numerous changes, including price management, the two-invoice system, DRG-based payment reforms, improvements to the multi-tiered healthcare system, and localized innovation.”

Xu Jingbo, Senior Investment Director at Fosun Pharma

Beyond gaining a thorough understanding of and fully leveraging the investment climate, numerous other factors are critical to entrepreneurial success. Among these, corporate administration, finance, legal compliance, and taxation constitute the fundamental pillars of business operations. Xiao Jinqing, a partner at AllBright Law Offices and one of the mentors, provided insights into the growth and development of startups from a legal perspective. He offered detailed explanations on issues of widespread concern to entrepreneurs, including equity incentives, equity financing, and initial public offerings (IPOs).

Xiao Jinqing, Partner at Commerce & Finance Law Offices

Fourteen high-quality startup projects, representing the first cohort of the Entrepreneurship Camp, conducted roadshows. These included Qingying Guangke, a R&D platform for novel angiographic X-ray systems; Huashi Nuowei, a R&D platform for disposable negative-pressure anterior chamber puncture needles; Alpha Regenerative Medicine, a high-tech innovative company in the field of stem cell regeneration; Bonao Medical, a team developing intelligent imaging analysis technology for brain diseases; Yun Anxing, providing intelligent system solutions for neurological disorders; Langrui Medical, an AI-based comprehensive ECG data service platform; Maixing Medical, a medical big data analytics service provider; Yihong Health, an enterprise offering rapid diagnostic tools for primary care; Huaxia Qingyi, a R&D team developing innovative CAR-T therapies for HIV-1; PulseFlow Technology, a globally leading platform for personalized diagnosis and treatment of cardiovascular and cerebrovascular diseases; Yiyi Medical, a provider of 3D medical imaging equipment; Huixian Medicine, a microfluidics-based rapid in vitro diagnostic platform; Siduoke, a wireless handheld ultrasound enterprise; and Shenzhi Technology, a high-tech innovative company in the field of medical imaging AI. Each project engaged in thorough one-on-one discussions with mentors from the Entrepreneurship Camp on-site, yielding significant insights and benefits.

In recent years, as public awareness of personal health has grown and market demand in the health sector has increased, China’s healthcare industry has seized a significant opportunity for rapid development, driven by favorable policies. This has attracted a surge of enterprises and capital into the healthcare space. The establishment of the Purple Cow Medical Startup Camp aims to help entrepreneurs overcome startup challenges, identify outstanding talent, and leverage industrial and financial resources to empower business growth, jointly driving the restructuring and upgrading of healthcare scenarios through new technologies.

An early- to mid-stage equity investment fund jointly founded in September 2015 by Fu Sheng, CEO of Cheetah Mobile, and Zhang Quanling, a former renowned CCTV host and journalist. The fund’s partners include prominent founders of listed companies and investors such as Fu Sheng, Zhang Quanling, Luo Zhenyu of Luoji Siwei (Logical Thinking), Zhang Ying of Matrix Partners China, Li Xueling of Duowan Games, Yao Jinbo of 58.com, Xu Xiaoping of ZhenFund, and Su Mang of Fashion Group.